CF vs. NTR: Which Fertilizer Giant Is the Better Pick Now?

The article is constructive on fertilizer demand and pricing, but favors CF Industries over Nutrien due to CF’s cheaper 7.26x forward P/E, higher expected 2026 EPS growth of 83.1%, and stronger dividend growth. CF also generated $1.79 billion of free cash flow in 2025 and returned $1.7 billion to shareholders, while Nutrien benefited from record potash volumes but faces higher sulfur and ammonia input costs pressuring phosphate margins. Overall, the piece suggests CF has the better near-term investment setup in a tight global nitrogen market.

Analysis

The market is rewarding the cleaner nitrogen lever. CF should continue to out-earn the group because its revenue sensitivity is more exposed to pricing than to incremental volume, and the current setup still looks like a mid-cycle tightness story rather than a peak-cycle squeeze. That matters because in fertilizer, the next leg of upside usually comes from earnings revisions, not headline commodity strength; CF appears to have that revision tailwind already, while NTR is still fighting margin drag from inputs.

The second-order effect is that NTR’s diversification is becoming a double-edged sword. Retail and potash provide resilience, but they also dilute operating leverage to the tightest part of the cycle, while phosphate is increasingly hostage to sulfur/ammonia inflation. If input inflation persists for another 1-2 quarters, NTR’s reported stability could mask weaker incremental returns versus CF’s more direct capture of nitrogen price upside.

The contrarian risk is that consensus may be overconfident in sustained tightness. Fertilizer markets can turn quickly if weather normalizes, corn acreage disappoints, or geopolitical supply is restored faster than expected; those are months-to-quarter risks, not years. CF’s valuation is still cheap, but cheap cyclicals often deserve a discount when margins are near local highs, so the key question is whether current earnings estimates embed enough moderation into 2027.

Relative positioning favors CF, but the better asymmetric setup may be a pair rather than a naked long. NTR’s higher dividend helps defend the stock, yet that same capital return commitment reduces flexibility if input costs stay elevated, potentially forcing slower buybacks right when investors want support most. For both names, the main catalyst window is the next 1-2 quarterly prints, where guidance on India imports, North American acres, and input-cost pass-through should determine whether the market continues to pay up for CF and maintain a discount on NTR.

Key Decisions for Investors

• Long CF / short NTR as a relative-value pair for the next 1-2 earnings cycles; CF has better earnings revision momentum and cleaner exposure to the tightest part of the nitrogen market, while NTR carries more input-cost risk.
• Add to CF on any pullback toward a sub-8x forward multiple; the risk/reward remains favorable as long as 2026 EPS revisions stay positive, but trim if guidance stops improving or nitrogen pricing rolls over.
• Avoid chasing NTR ahead of quarterly results; use it as a defensive income name only if you want the dividend, because the upside is capped unless phosphate margins improve or input costs ease.
• For options traders, buy 3-6 month CF call spreads financed by selling higher-strike calls; this captures upside from continued estimate revisions while limiting premium outlay in a potentially peak-multiple name.
• Set a tactical hedge on both names with a short-dated fertilizer basket against a macro slowdown thesis; demand destruction or a fast normalization in supply is the cleanest way to unwind the trade.